SEC Form 4 · accession 0001144204-18-004100
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Bright
Officer — President International
Period of report
Aug 1, 2017
Accepted (ET)
Jan 26, 2018 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2017 | A | 293 | $0.00 | A | 23,127 | D | |
| Common StockF1 | Dec 18, 2017 | A | 879 | $0.00 | A | 24,006 | D | |
| Common StockF1 | Jan 8, 2018 | A | 879 | $0.00 | A | 24,885 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares vested upon the satisfaction of certain performance milestones.